BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8258325)

  • 1. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice.
    Marusić-Galesić S; Udaka K; Walden P
    Eur J Immunol; 1993 Dec; 23(12):3115-9. PubMed ID: 8258325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
    J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone.
    McAdam AJ; Blieden TM; Frelinger JG; Lord EM
    Eur J Immunol; 1992 Sep; 22(9):2461-4. PubMed ID: 1516633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
    Udaka K; Marusić-Galesić S; Walden P
    J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E; McCarthy SA
    Cell Immunol; 1997 Aug; 179(2):107-15. PubMed ID: 9268494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.
    Pullen LC; Miller SD; Dal Canto MC; Kim BS
    Eur J Immunol; 1993 Sep; 23(9):2287-93. PubMed ID: 8370406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cells from major histocompatibility complex class II-deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reaction.
    Shimizu T; Takeda S
    Eur J Immunol; 1997 Feb; 27(2):500-8. PubMed ID: 9045923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.
    Ladel CH; Flesch IE; Arnoldi J; Kaufmann SH
    J Immunol; 1994 Oct; 153(7):3116-22. PubMed ID: 7726898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells.
    Schleussner C; Ceredig R
    Eur J Immunol; 1993 Jul; 23(7):1615-22. PubMed ID: 8391987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.
    Tarleton RL; Koller BH; Latour A; Postan M
    Nature; 1992 Mar; 356(6367):338-40. PubMed ID: 1549177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
    Hou S; Doherty PC; Zijlstra M; Jaenisch R; Katz JM
    J Immunol; 1992 Aug; 149(4):1319-25. PubMed ID: 1354233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.
    Jhaver KG; Rao TD; Frey AB; Vukmanović S
    J Immunol; 1995 Jun; 154(12):6252-61. PubMed ID: 7759863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.